" class="no-js "lang="en-US"> The Royal Marsden NHS Foundation Trust - Medtech Alert
Saturday, May 31, 2025
The Royal Marsden | Pharmtech Focus

The Royal Marsden NHS Foundation Trust

About The Royal Marsden NHS Foundation Trust

The Royal Marsden NHS Foundation Trust

The Royal Marsden is a world-leading cancer centre specialising in cancer diagnosis, treatment, research and education. We have two hospitals: one in Chelsea, London, and another in Sutton, Surrey. Also in Surrey, we have a Medical Daycare Unit in Kingston. We are also partners with The Institute of Cancer Research. Through this partnership, we undertake groundbreaking research into new cancer drug therapies and treatments. The partnership makes us the biggest and most comprehensive cancer centre in Europe, with a combined staff of 3,500. The Royal Marsden was founded in 1851 by William Marsden. His vision was to create a pioneering cancer hospital dedicated to excellence in the study, treatment and care of people with cancer. Today we continue to build on this legacy, constantly raising standards to improve the lives of the 40,000 cancer patients from across the UK and abroad that we see each year.

Related Story

MHRA Grants Marketing Authorisation for Novartis’ Radioligand Therapy Pluvicto®▼ (Lutetium (¹⁷⁷lu) Vipivotide Tetraxetan) in Advanced Prostate Cancer in Great Britain

August 15 2022

Advanced Accelerator Applications (AAA), a Novartis company,  today announced that the Medicines & Healthcare products […]

Owkin, the Francis Crick Institute and the Royal Marsden NHS Foundation Trust to Use AI to Research Kidney Cancer Evolution

July 22 2022

Owkin is partnering with scientists from the Francis Crick Institute and The Royal Marsden NHS […]